MAIA Biotechnology Inc

Research MAIA Biotechnology Inc (MAIA) on Bullrun: market cap USD 89.99M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMAIA
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 89.99M
• Financial periodFY2025
• Net income-USD 22.40M

Valuation Snapshot

latest market cap is USD 89.99M.

About MAIA Biotechnology Inc

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Frequently asked questions

What is MAIA Biotechnology Inc's market cap?

MAIA Biotechnology Inc's market capitalization is USD 89.99M.

What does MAIA Biotechnology Inc do?

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer.